Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-20-032403)

Filing Details

Accession Number:: 0001209191-20-032403
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-05-27 18:27:23
Reporting Period:: 2020-05-27

Accepted Time:: 2020-05-27 18:27:23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1531048	Inari Medical Inc.	NARI	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1304099	William Hoffman	C/O Inari Medical, Inc. 9 Parker, Suite 100 Irvine CA 92618	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-05-27	13,095	$19.00	1,232,283	No	4	P	Direct
Common Stock	Acquisiton	2020-05-27	89,633	$0.00	1,321,916	No	4	C	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	C	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Preferred Stock	Disposition	2020-05-27	29,925	$0.00	29,925	$0.00
Common Stock	Series C Preferred Stock	Disposition	2020-05-27	59,708	$0.00	59,708	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct
0			No	4	C	Direct

Footnotes

Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one basis.